Immunotherapy in the Management of Lung Cancer
| bracu.type.group | Student Works | |
| dc.contributor.advisor | khan, Tanisha Tabassum Sayka | |
| dc.contributor.author | Tasnim, Humayra | |
| dc.contributor.department | Department of Pharmacy | |
| dc.date.accessioned | 2022-10-17T06:27:07Z | |
| dc.date.available | 2022-10-17T06:27:07Z | |
| dc.date.copyright | 2021 | |
| dc.date.issued | 2021-11 | |
| dc.description | Cataloged from PDF version of thesis report. | |
| dc.description | Includes bibliographical references (pages 42-53). | |
| dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. | en_US |
| dc.description.abstract | Among all the major cancer types, lung cancer is one of the most common as it holds a higher percentage of cancer related mortality and treating lung cancer is yet a challenge. Chemotherapy, radiation therapy, surgery are the most commonly used and traditional treatment options for lung cancer but these possess side effects and various complications. Therefore, to minimize the side effects, a novel treatment option is needed and it is cancer immunotherapy. Immunotherapy is a new way to treat cancer that can attack tumor cells by using the host's immune system. Various immunotherapy drugs have been evaluated for lung cancer. This review focused on the relation between cancer and immune system, new immunotherapy treatment options for lung cancer as well as the challenges and prospects of cancer immunotherapy. | |
| dc.description.degree | Bachelor of Pharmacy | |
| dc.description.statementofresponsibility | Humayra Tasnim | |
| dc.format.extent | 53 Pages | |
| dc.identifier.other | ID: 17146054 | |
| dc.identifier.uri | http://hdl.handle.net/10361/17515 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | BRAC University | en_US |
| dc.rights | Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
| dc.subject | Lung cancer | en_US |
| dc.subject | Immunotherapy | en_US |
| dc.subject | Cytokines | en_US |
| dc.subject | Checkpoint inhibitors | en_US |
| dc.subject | Adoptive cell therapy | en_US |
| dc.subject | Vaccines | en_US |
| dc.subject.lcsh | Cancer--Treatment | |
| dc.subject.lcsh | Cancer--Immunotherapy | |
| dc.title | Immunotherapy in the Management of Lung Cancer | en_US |
| dc.type | Thesis | en_US |